1. Home
  2. Analysis
  3. Rezulin
  4. Hypophagia

Rezulin and Hypophagia - a phase IV clinical study of FDA data

Summary:

Hypophagia is reported as a side effect among people who take Rezulin (troglitazone), especially for people who are female, 60+ old, also take Avandia, and have Breast cancer.

The phase IV clinical study analyzes which people have Hypophagia when taking Rezulin. It is created by eHealthMe based on reports of 8,761 people who have side effects when taking Rezulin from the FDA, and is updated regularly.

What is Rezulin?

Rezulin has active ingredients of troglitazone. eHealthMe is studying from 8,764 Rezulin users. Check the latest studies of Rezulin.

What is Hypophagia?

Hypophagia (reduced food intake) is found to be associated with 1,481 drugs and 1,395 conditions by eHealthMe. Check the latest studies of Hypophagia.

On Aug, 06, 2026

8,761 people reported to have side effects when taking Rezulin.
Among them, 11 people (0.13%) have Hypophagia.

Could Rezulin cause Hypophagia?

Among these 11 people:

What is the gender of people who have Hypophagia when taking Rezulin? *

  • female: 90.91 %
  • male: 9.09 %

What is the age of people who have Hypophagia when taking Rezulin? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 9.09 %
  • 60+: 90.91 %

What are other drugs people take besides Rezulin? *

  1. Levaquin: 11 people, 100.00%
  2. Avandia: 11 people, 100.00%
  3. Lasix: 9 people, 81.82%
  4. Accupril: 8 people, 72.73%
  5. Dyazide: 8 people, 72.73%
  6. Dalmane: 8 people, 72.73%
  7. Nystatin: 8 people, 72.73%
  8. Daypro: 8 people, 72.73%
  9. Detrol: 8 people, 72.73%
  10. Neurontin: 8 people, 72.73%

What are other side effects people have besides Hypophagia? *

  1. International Normalised Ratio Increased: 11 people, 100.00%
  2. Cardiac Failure Congestive: 11 people, 100.00%
  3. Acute Kidney Failure: 11 people, 100.00%
  4. Urinary Tract Infection: 11 people, 100.00%
  5. Dehydration (dryness resulting from the removal of water): 11 people, 100.00%
  6. Arrhythmias (irregular heartbeat): 11 people, 100.00%
  7. Azotaemia (excess of urea or other nitrogenous compounds in the blood): 10 people, 90.91%
  8. Confusional State: 10 people, 90.91%
  9. Weakness: 9 people, 81.82%
  10. Fatigue (feeling of tiredness): 9 people, 81.82%

What are the existing conditions these people have? *

  1. Metastases To Bone (cancer spreads to bone): 7 people, 63.64%
  2. Breast Cancer: 7 people, 63.64%
  3. Lung Cancer - Non-Small Cell (lung cancer): 1 person, 9.09%
  4. Breast Cancer Metastatic: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Rezulin and have Hypophagia?

- Check whether Hypophagia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rezulin:

Hypophagia treatments and more:

How severe was Hypophagia and when was it recovered:

Expand to all the drugs that have ingredients of troglitazone:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Rezulin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypophagia:

Browse all the conditions that are associated with Hypophagia:

How the study uses the data?

The study uses data from the FDA. It is based on troglitazone (the active ingredients of Rezulin) and Rezulin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.